CME Group (BSP:CHME34) Cyclically Adjusted Revenue per Share: R$4.44 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:CHME34 CME Group Inc BSP:CHME34
87 GF Score
Price R$63.47
GF Value R$70.83
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is CME Group Cyclically Adjusted Revenue per Share?

CME Group BSP:CHME34 87 Cyclically Adjusted Revenue per Share is R$4.44 as of Jun. 2026. GuruFocus rates BSP:CHME34 with a GF Score™ of 87/100 and a GF Value™ of R$70.83 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

CME Group's adjusted revenue per share for the three months ended in Jun. 2026 was R$1.210. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$4.44 for the trailing ten years ended in Jun. 2026.

During the past 12 months, CME Group's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.00% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of CME Group was 9.30% per year. The lowest was 4.50% per year. And the median was 6.10% per year.

As of today (2026-07-29), CME Group's current stock price is R$63.468. CME Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was R$4.44. CME Group's Cyclically Adjusted PS Ratio of today is 14.29.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CME Group was 20.54. The lowest was 10.42. And the median was 15.64.


CME Group  (BSP:CHME34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

CME Group's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=63.468/4.44
=14.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CME Group was 20.54. The lowest was 10.42. And the median was 15.64.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


CME Group Cyclically Adjusted Revenue per Share Related Terms


CME Group Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for CME Group's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CME Group Cyclically Adjusted Revenue per Share Chart

CME Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.46 3.56 3.55 4.96 4.61

CME Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.29 4.31 4.61 4.32 4.44

BSP:CHME34 vs ICE, MCO, SPGI: Cyclically Adjusted Revenue per Share Comparison

For the Financial Data & Stock Exchanges subindustry, CME Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CME Group Cyclically Adjusted PS Ratio vs Capital Markets Industry

For the Capital Markets industry and Financial Services sector, CME Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CME Group's Cyclically Adjusted PS Ratio falls into.


BSP:CHME34
87GF Score
CME Group Inc BSP:CHME34
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CME Group Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CME Group's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.21/333.9520*333.9520
=1.210

Current CPI (Jun. 2026) = 333.9520.

CME Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.404 241.428 0.559
201612 0.451 241.432 0.624
201703 0.427 243.801 0.585
201706 0.448 244.955 0.611
201709 0.410 246.819 0.555
201712 0.435 246.524 0.589
201803 0.534 249.554 0.715
201806 0.586 251.989 0.777
201809 0.545 252.439 0.721
201812 0.682 251.233 0.907
201903 0.633 254.202 0.832
201906 0.685 256.143 0.893
201909 0.734 256.759 0.955
201912 0.652 256.974 0.847
202003 1.037 258.115 1.342
202006 0.856 257.797 1.109
202009 0.814 260.280 1.044
202012 0.788 260.474 1.010
202103 0.984 264.877 1.241
202106 0.826 271.696 1.015
202109 0.816 274.310 0.993
202112 0.904 278.802 1.083
202203 0.933 287.504 1.084
202206 0.869 296.311 0.979
202209 0.896 296.808 1.008
202212 0.882 296.797 0.992
202303 1.045 301.836 1.156
202306 0.918 305.109 1.005
202309 0.919 307.789 0.997
202312 0.980 306.746 1.067
202403 1.030 312.332 1.101
202406 1.147 314.175 1.219
202409 1.219 315.301 1.291
202412 1.292 315.605 1.367
202503 1.313 319.799 1.371
202506 1.302 322.561 1.348
202509 1.144 324.800 1.176
202512 1.248 324.054 1.286
202603 1.354 330.213 1.369
202606 1.210 333.952 1.210

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$4.44 mean?
CME Group (BSP:CHME34) has a Cyclically Adjusted Revenue per Share of R$4.44 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CME Group and its competitors.
Is CME Group's Cyclically Adjusted Revenue per Share too high?
CME Group's current Cyclically Adjusted Revenue per Share is R$4.44. Overall, CME Group has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Cyclically Adjusted Revenue per Share compare to ICE and MCO?
CME Group's Cyclically Adjusted Revenue per Share of R$4.44 can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Capital Markets company?
A good Cyclically Adjusted Revenue per Share depends on the Capital Markets industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CME Group and its competitors. CME Group's current Cyclically Adjusted Revenue per Share is R$4.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (BSP:CHME34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$70.83, compared to a current price of R$63.47 — trading 10.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is R$4.44. CME Group's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For CME Group (BSP:CHME34), the current Cyclically Adjusted Revenue per Share is R$4.44 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CME Group (BSP:CHME34) Overvalued in 2026?

Based on GuruFocus' analysis, CME Group stock appears to be undervalued. The current stock price of R$63.47 is trading 10.4% below its estimated GF Value™ of R$70.83. GuruFocus considers CME Group to be Modestly Undervalued.

Key valuation signals for BSP:CHME34:

  • Cyclically Adjusted Revenue per Share: R$4.44
  • GF Value™: R$70.83 vs. price of R$63.47 (10.4% below fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the BSP:CHME34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CME Group Business Description

Address 20 South Wacker Drive, Chicago, IL, USA, 60606
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
87GF Score

Get the complete analysis for BSP:CHME34

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$63.47
Price
R$70.83
GF Value